ClinicalTrials.gg
Status unknownNCT04798885GAIN2Updated Nov 13, 2023

Get Going After concussioN 2.0

An interventional study of GAIN 2.0 in Commotio Cerebri and Mild Traumatic Brain Injury, sponsored by University of Aarhus. Status unknown at 1 site in Denmark. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2023-11-13.

Sponsored by University of Aarhus · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Nov 2023), so the status shown — last known as Active, not recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
310
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

The study tests the promising results of a previous study (GAIN 1.0) in a larger RCT (GAIN 2.0) which takes place in the municipalities of Central Denmark Region where citizens live their daily lives and whose health- and social care systems support citizens who experience persisting PCS.

Read the detailed description

Concussion, the mildest form of traumatic brain injury, is an important public health concern. Recent studies estimate that persistent post-concussion symptoms (PCS) are present in almost half of the affected citizens at one year post-injury. Prospective studies have demonstrated that these citizens are at risk of developing long-lasting symptoms which are associated with high societal burden due to long-term impact on labour market attachment and increased use of health care and social benefits. In Denmark, there has in recent years been an increasing awareness on societal impact and personal consequences of PCS. Accordingly, clinicians as well as social workers and therapists in the municipalities point to the gab in knowledge concerning PCS and advocate urgently for evidence-based treatment for these citizens. Recently, the research group behind this application developed a novel early intervention - "Get going After concussIoN" (GAIN 1.0) - for citizens who experience persistent PCS three to six months post-concussion. The intervention was tested in a randomized controlled trial (RCT) with promising results. However, it was delivered in a single hospital setting in which these citizens are normally not cared for. In this study the intention is to test the results of GAIN 1.0 in a larger RCT (GAIN 2.0) which takes place in the municipalities of Central Denmark Region where citizens live their daily lives and whose health- and social care systems support citizens who experience persisting PCS.

02

Conditions studied

  • Commotio Cerebri
  • Mild Traumatic Brain Injury

Browse trials for

03

In context

Brain Concussion

550 studies on the registry are indexed under Brain Concussion; 154 are open to participants now.

This study's enrollment of 310 is above the median of 64 across 376 interventional studies indexed under Brain Concussion.

Browse Brain Concussion studies →

Lead sponsor

University of Aarhus is the lead sponsor of 1,299 studies on the registry; 189 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Concussion caused by a head trauma according to the diagnostic criteria recommended by WHO. Participants must be referred to the project within two to four months of injury.
  2. Age 18 to 60 years at the time of the trauma
  3. A RPQ score ≥20.
  4. Able to understand, speak and read Danish.
  5. Living in Central Denmark Region.

Exclusion criteria

Exclusion Criteria:

  1. Objective neurological findings and/or acute trauma CT scan indicating neurological disease or brain damage.
  2. Previous concussion leading to persistent PCS within the last two years.
  3. Severe misuse of alcohol, prescription drugs and/or illegal drugs.
  4. Psychiatric morbidity or severe neurological disease that impedes participation in the program, i.e. Bipolar Disorder, autism, psychotic disorder (life time), multiple sclerosis etc.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
310 participants (actual)

Study arms

  • No intervention
    Enhanced usual care

    Participants will be informed about typical Post Concussion Symptoms and the process of typical recovery as well as given reassurance concerning the prognosis. Advice concerning the use of pain relief medication will also be provided.

  • Experimental
    GAIN 2.0 intervention

    An eight-week, interdisciplinary intervention program based on principles from cognitive behavioural therapy (CBT) and gradual return to activities.

    Behavioral: GAIN 2.0

Interventions

  • BehavioralGAIN 2.0

    1\) three structured group sessions of two hours duration performed jointly by a neuropsychologist, an occupational therapist and a physiotherapist. Relatives are also invited. 2) Up to five weekly semi-structured individual sessions of 30 min. duration with an allocated therapist

06

What researchers measure

Primary outcomes

  1. Change of at least seven in the sum score on the Rivermead Post-Concussion Symptoms Questionnaire (RPQ)

    RPQ is a self-report scale to measure the severity of Post Concussion Symptoms covering physical, cognitive, and emotional symptoms with 16 sub-items and a total sum score (range 0-64, higher score define more severe status)

    Time frame: Three months after end of treatment

Secondary outcomes

  1. Sumscore in the dimension 'time spend on daily activities' on the Utrecht Scale for Evaluation of Rehabilitation-Participation (USER-P).

    Utrecht Scale for Evaluation of Rehabilitation-Participation is a generic measurement that both objectively and subjectively measure participation in Instrumental Activities of Daily Living (IADL) such as work, voluntary work, education, family duties and responsibilities, leisure activities, transportation, communication and social activities in three dimensions. The sumscore in each dimension is converted to a 0-100 metric with higher scores meaning af better outcome.

    Time frame: Three months after end of treatment

  2. Sumscore in the dimension 'limitations' on the Utrecht Scale for Evaluation of Rehabilitation-Participation (USER-P)

    Utrecht Scale for Evaluation of Rehabilitation-Participation is a generic measurement that both objectively and subjectively measure participation in Instrumental Activities of Daily Living (IADL) such as work, voluntary work, education, family duties and responsibilities, leisure activities, transportation, communication and social activities in three dimensions.The sumscore in each dimension is converted to a 0-100 metric with higher scores meaning af better outcome.

    Time frame: Three months after end of treatment

  3. Sumscore in the dimension 'satisfaction with participation' on the Utrecht Scale for Evaluation of Rehabilitation-Participation (USER-P)

    Utrecht Scale for Evaluation of Rehabilitation-Participation is a generic measurement that both objectively and subjectively measure participation in Instrumental Activities of Daily Living (IADL) such as work, voluntary work, education, family duties and responsibilities, leisure activities, transportation, communication and social activities in three dimensions.The sumscore in each dimension is converted to a 0-100 metric with higher scores meaning af better outcome.

    Time frame: Three months after end of treatment

  4. Long term sick leave defined as public assistance benefits related to illness in more than three consecutive weeks

    Calculated based on weekly public assistance benefits extracted from the DREAM register

    Time frame: Within 12 months after concussion

  5. Cumulated incidence proportion of participants on long term sick leave defined as receiving public assistance benefits related to illness in more than three consecutive weeks

    Calculated based on weekly public assistance benefits extracted from the DREAM register

    Time frame: Within 36 months after concussion

  6. Proportion of employed participants defined as receiving no public assistance benefits except from state education fund grants

    Calculated based on weekly public assistance benefits extracted from the DREAM register

    Time frame: At 12 months after concussion

  7. Proportion of employed participants defined as receiving no public assistance benefits except from state education fund grants

    Calculated based on weekly public assistance benefits extracted from the DREAM register

    Time frame: At 36 months after concussion

  8. Degree of job stability based on whether labor market contributions have been paid

    Monthly measure extracted from the DREAM register

    Time frame: At 12 months after concussion

  9. Degree of job stability based on whether labor market contributions have been paid

    Monthly measure extracted from the DREAM register

    Time frame: At 36 months after concussion

07

Study locations

1 site
  • Regionshospitalet Hammel Neurocenter
    Hammel, 8450, Denmark
08

References and documents

Publications

  • Naess-Schmidt ET, Thastum MM, Stabel HH, Odgaard L, Pedersen AR, Rask CU, Silverberg ND, Schroder A, Nielsen JF. Interdisciplinary intervention (GAIN) for adults with post-concussion symptoms: a study protocol for a stepped-wedge cluster randomised trial. Trials. 2022 Jul 29;23(1):613. doi: 10.1186/s13063-022-06572-7. PubMed 35906645 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 13, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04798885
Collaborators
Sygeforsikringen danmark, Hammel Neurorehabilitation Centre and University Research Clinic, Municipalities in Central Denmark Region
Responsible party
Sponsor
First posted
Mar 15, 2021
Start date
May 12, 2021
Primary completion
Jun 1, 2023
Completion
Sep 1, 2024 (estimated)
Last update
Nov 13, 2023

Study contacts

Jørgen F Nielsen, Professor
principal investigator · Hammel Neurorehabilitation Centre and University clinic

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion